News
11h
News-Medical.Net on MSNTargeting METTL3 may offer new hope for oral cancer treatmentA new research paper was published in , Volume 16, on May 8, 2025, titled "METTL3 promotes oral squamous cell carcinoma by regulating miR-146a-5p/SMAD4 axis." ...
Oral squamous cell carcinoma (OSCC) is a leading cause of cancer-related deaths, and early detection is key to improving patient outcomes. However, the mechanisms driving the transition from ...
The chef was diagnosed with stage 4 squamous cell carcinoma tongue cancer in May 2024 Shirley Chung is reflecting on her ...
8h
Belfast Live on MSNBelfast man's cancer diagnosis - 'I sounded like I smoked 40 cigarettes a day'"You hear about cancer, but you never think it’s going to happen on your own front door. When I was first told, I can’t even ...
Oral cancer is a type of cancer that affects the tissues in your mouth or throat ... The flat cells that cover the surfaces of your mouth, tongue, and lips are called squamous cells.
Don't ignore those symptoms. Head and neck cancers are far more manageable, and often curable, with less aggressive treatment ...
METTL3, an oncogene regulates the expression of SMAD4, a tumor-suppressor via miR-146a-5p, thus unveiling a novel regulatory axis ...
First-line treatment with a Keytruda combo had an overall survival of 17.6 months in some with recurrent/metastatic head and ...
Ending a 20-year-plus drought, Merck & Co.’s Keytruda demonstrated that its use around surgery can reduce the risk of certain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results